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The synthesis and spectroscopic characterisation of novel mononuclear RuIII(edta)(hydroxamato)
complexes of general formula [Ru(H2edta)(monoha)] (where monoha = 3- or 4-NH2, 2-, 3- or 4-Cl and
3-Me-phenylhydroxamato), as well as the ﬁrst example of a RuIII-N-aryl aromatic hydroxamate,
[Ru(H2edta)(N-Me-bha)]·H2O (N-Me-bha = N-methylbenzohydroxamato) are reported. Three
dinuclear RuIII complexes with bridging dihydroxamato ligands of general formula
[{Ru(H2edta)}2(l-diha)] where diha = 2,6-pyridinedihydroxamato and 1,3- or
1,4-benzodihydroxamato, the ﬁrst of their kind with RuIII, are also described. The speciation of all of
these systems (with the exception of the Ru–1,4-benzodihydroxamic acid and
Ru–N-methylbenzohydroxamic systems) in aqueous solution was investigated. We previously proposed
that nitrosyl abstraction from hydroxamic acids by RuIII involves initial formation of
RuIII-hydroxamates. Yet, until now, no data on the rate of nitric oxide (NO) release from hydroxamic
acids has been published. We now describe a UV-VIS spectroscopic study, where we monitored the
decrease in the ligand-to-metal charge-transfer band of a series of RuIII-monohydroxamates with time,
with a view to gaining an insight into the NO-releasing properties of hydroxamic acids.
Introduction
Hydroxamic acids RC(O)NHOH have emerged in recent years
as a class of compounds that can fulﬁl a variety of roles in
biology and medicine, many of which are as a result of their
enzyme-inhibitory properties.1,2 The versatile biological activity
of hydroxamic acids is undoubtedly due to their ability to
form stable metal chelates,1,2 and possibly their NO-releasing
properties.3 In addition, when deprotonated, the hydroxamate
anion (RCOHNO−) can form salt linkages in their complexes
with proteins, and when neutral (RCOHNOH) may engage in
important hydrogen-bonding interactions.1
The powerful metal-chelating ability of hydroxamic acids has
also been utilised to construct a diverse host of fascinating
metal complexes including hydroxamates,1,4–8 hydroximates1,4,9 and
examples in supramolecular chemistry such asmetallacrowns,1,10,11
coordination polymers12 and tetrahedral cluster complexes.13
One of the ﬁrst physiological roles of hydroxamic acids was
associated with their use as siderophores, a class of low molec-
ular weight iron (Fe)-sequestering agents involved in microbial
iron transport. As a result, the chemistry of FeIII-hydroxamato
complexes has been extensively studied, with numerous X-ray
structural reports of and determination of stability constants
for FeIII complexes with synthetic and naturally occurring hy-
droxamic acids. Typically, hydroxamic acids coordinate FeIII in
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† Electronic supplementary information (ESI) available: Titration curves.
See DOI: 10.1039/b711863e
an O,O′-bidentate manner to form stable metal chelates with
characteristically high formation constants. Desferal, for example,
a trihydroxamic acid used clinically as anFe scavenger, coordinates
to FeIII via its three hydroxamato moieties, forming an FeIII-
trishydroxamate with log b ∼30.1
Despite such an active interest in hydroxamato complexes of
FeIII, surprisingly there is only one literature report to date on their
complexes with RuIII. In this, the ﬁrst structurally characterised
RuIII hydroxamato complex, [Ru(H2edta)(2-MeO-pha)] (where 2-
MeO-pha is 2-methoxyphenylhydroxamato) (Fig. 1 ), and the
synthesis and spectroscopic characterisation of several others are
reported.14
Fig. 1 Structure of [Ru(H2edta)(2-OMe-pha)].
The speciation and stability constants for several mononuclear
RuIII-hydroxamato complexes were also reported in addition to
their relative afﬁnity for RuIII over FeIII.14 We now report the
syntheses and spectroscopic characterisation of three dinuclear
RuIII-complexes with bridging dihydroxamato ligands, the ﬁrst of
their kind with RuIII to be reported as well as a series of novel
mononuclear RuIII-hydroxamato complexes, including the ﬁrst
This journal is © The Royal Society of Chemistry 2008 Dalton Trans., 2008, 137–147 | 137
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example of a RuIII-N-aryl aromatic hydroxamato derivative. The
speciation of all of these systems (with the exception of theRu–1,4-
benzodihydroxamic acid and the Ru–N-methylbenzohydroxamic
acid systems) in aqueous solution was investigated and is also
herein reported.
We previously proposed that nitrosyl abstraction from hy-
droxamic acids by K[Ru(Hedta)Cl] involves initial formation of
RuIII-hydroxamato complexes with the subsequent formation of
the RuII-nitrosyl [RuII(Hedta)(NO)Cl]− and the corresponding
carboxylic acid.3 Yet, until now, no data on the rate of NO release
from hydroxamic acids have been published. We have carried out
a UV-VIS spectroscopic investigation in which we monitored the
decrease in the hydroxamato ligand-to-Ru metal charge-transfer
band of a series of RuIII-hydroxamato complexes with time, with
a view to gaining an insight into the NO-releasing properties of
hydroxamic acids.
Experimental
Materials and instrumentation
Benzohydroxamic acid (bhaH), acetohydroxamic acid (achaH),
benzoyl chloride, the ester reagents and deuterated solvents were
all purchased from Aldrich and used without further puriﬁcation.
RuCl3·xH2O was kindly donated by Johnson Matthey. IR spectra
were recorded asKBr discs (4000–400 cm−1) on aMattsonGenesis
IICSIFTIR spectrometer and the spectra analysedusingWinFirst
software. 1H NMR spectra were recorded on a Bruker Avance
400 MHz NMR spectrometer and the spectra analysed using
TopSpin 1 software. The residual undeuterated DMSO signal at
2.505 ppm or the Me4Si signal were used as internal references.
UV-VIS spectra were performed on a Helios aThermo Spectronic
Spectrophotometer in a quartz cell. Liquid chromatography-mass
spectrometry experiments were performed on a Quattro Micro
quadrupole electrospray mass spectrometer (Micromass, Waters
Corp., USA); 10 lL of the samples were injected in 300 lL of
acetonitrile–water (60 : 40, v/v). The mass spectrometry data
were acquired both in positive and negative ion modes. Magnetic
measurements were carried out on polycrystalline samples using
a Sherwood Scientiﬁc Magnetic Susceptibility Balance. Elemental
analysis (C, H, N, Cl & K) were performed at the Microanalytical
Laboratory, School of Chemistry and Chemical Biology, Univer-
sity College Dublin.
Syntheses
Synthesis of N-aryl aromatic hydroxamic acid
N-Methylbenzohydroxamic acid (N-Me-bhaH)15
N-Methylhydroxylamine hydrochloride (2.36 g, 28 mmol) was
added to sodium carbonate (3.65 g, 34 mmol) in deionised water
(50 cm3) under nitrogen. The solution was covered with diethyl
ether (20 cm3). Benzoyl chloride (4.06 cm3, 35 mmol) in diethyl
ether (30 cm3) was added dropwise over 10 minutes to the stirring
heterogeneousmixture in an ice–salt bath. Themixture was stirred
and then cooled for a further 30 minutes, after which 20% sodium
hydroxide (12 cm3) was added. The aqueous layer was neutralised
to pH 7 with 6 M HCl, saturated with sodium chloride and
extracted ﬁve times with chloroform. The chloroform was dried
withmagnesium sulfate and then removed in vacuo affording a tan-
coloured oil, which was puriﬁed by column chromatography on
silica using ethyl acetate–n-heptane as eluent to give N-Me-bhaH
(0.95 g, 23%) as a colourless oil: dH (400 MHz; CDCl3) 7.31–7.43
(5H, m, ar H), 2.94 (s, 3H, CH3).
Syntheses of mono- and dihydroxamic acids
A series of mono- and dihydroxamic acids, listed in Table 1, were
synthesised by reaction of hydroxylamine with the corresponding
methyl or ethyl esters according to the method described for 1,4-
benzodihydroxamic acid below. 1HNMRand selected IRdata and
elemental analyses for each of the hydroxamic acids synthesised
may also be found in Table 1.
1,4-Benzodihydroxamic acid, terephthalohydroxamic acid
(1,4-bhaH2)
Hydroxylamine hydrochloride (6.3 g, 90 mmol) was mixed with
sodium hydroxide (7.2 g, 180 mmol) in deionised water (45 cm3).
The solution was then added to dimethyl terephthalate (5.8 g,
30 mmol) in methanol (50 cm3). The resulting solution was stirred
for 72hours at 40 ◦Candwas acidiﬁed topH5.5using 5%HCl.The
solvent was removed in vacuo yielding a yellow solid. Methanol
(60 cm3) was added and sodium chloride ﬁltered. The solvent was
removed in vacuo yielding a white solid, which was recrystallised
from water to give 1,4-bhaH2 (3.4 g, 58%) as a white crystalline
solid (Found: C, 48.7; H, 4.1; N, 14.1%. Calc. for C8H8N2O4: C,
49.0; H, 4.0; N, 14.3%); dH (400 MHz, DMSO): 11.33 (2H, br s,
OH), 9.14 (2H, br s, NH) and 7.81 (4H, s, aromatic H); mmax/cm−1
3288vs (NH), 2730b (OH), 1649vs, 1612vs (CO) and 1562s (CN).
Syntheses of RuIII complexes
K[Ru(Hedta)Cl]·2H2O (1)
K[Ru(Hedta)Cl]·2H2O (4.6 g, 63%) was prepared by modiﬁcation
of a literature method16 (Found: C, 23.8; H, 3.3; N, 5.4; Cl, 7.0; K,
7.6%. Calc. for RuC10H17N2O11ClK: C, 24.0; H, 3.4; N, 5.6; Cl, 7.1;
K, 7.8%); mmax/cm−1 3410s (OH), 2992s, 2942s (CH, CH2), 1726s
(CO, free glycine arm), and 1632s (CO, bound glycinato arms).
[Ru(H2edta)(N-Me-bha)]·H2O (2)
An ethanolic solution (10 cm3) of N-methylbenzohydroxamic
acid (N-Me-bha) (0.22 g, 1.45 mmol) was added to an aqueous
solution (25 cm3) of K[Ru(Hedta)Cl]·2H2O (0.56 g, 1.12 mmol).
The reaction was stirred for 2 hours. A red precipitate 2 (0.56 g,
83%) was ﬁltered and dried over P2O5 (Found: C, 38.5; H, 4.3;
N, 7.4%. Calc. for RuC18H24N3O11: C, 38.6; H, 4.3; N, 7.5%);
mmax/cm−1 3494vs (NCH3), 1722vs (CO, free glycine arms), 1640vs
(CO, glycinato) and 1611vs (CO, hydroxamato); ESI-MSm/z: 543
([M + H]+); leff = 1.89 lB.
Complexes 4–14 were synthesised according to the method
described for [{Ru(H2edta)}2(l-1,4-bha)]·2H2O below. In all cases
the reaction solutions were concentrated in vacuo before being
left overnight in a refrigerator whereupon solids precipitated over
time. Numerous attempts were made to isolate crystals suitable for
an X-ray crystallographic study but to no avail.
138 | Dalton Trans., 2008, 137–147 This journal is © The Royal Society of Chemistry 2008
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[{Ru(H2edta)}2(l-1,4-bha)]·2H2O (3)
Anaqueous solution (20 cm3) of 1,4-benzodihydroxamic acid (0.15
g, 0.75 mmol) was added to an aqueous solution (15 cm3) of
K[Ru(Hedta)Cl]·2H2O (0.75 g, 1.50 mmol) in deionised water (15
cm3). The reaction was stirred for 3 hours, concentrated in vacuo
and left to stand in a refrigerator overnight. A red precipitate 3
(0.70 g, 46%) was ﬁltered and dried over P2O5 (Found: C, 33.1;
H, 4.0; N, 8.5%. Calc. for Ru2C28H38N6O22: C, 33.2; H, 3.8; N,
8.3%); mmax/cm−1 3288vs (NH), 1724vs (CO, free glycine arms),
1668vs (CO, glycinato) and 1609vs (CO, hydroxamato); ESI-MS
m/z: 977 ([M–H]−); leff = 2.16 lB.
[{Ru(H2edta)}2(l-1,3-bha)]·4H2O (4)
Yield: 0.48 g, 80%. (Found: C, 31.8; H, 3.7; N, 8.0%. Calc. for
Ru2C28H42N6O24: C, 31.5; H, 3.4; N, 7.8%); mmax/cm−1 3213s (NH),
1732vs (CO, free glycine arms) and 1639vs (CO, glycinato and
hydroxamato); ESI-MS m/z: 977 ([M–H]−).
[{Ru(H2edta)}2(l-2,6-pyha)]·4H2O (5)
Yield: 0.29 g, 28%. (Found: C, 30.6; H, 3.5; N, 9.0%. Calc. for
Ru2C27H41N7O24: C, 30.9;H, 3.9;N, 9.3%); mmax/cm−1 3265vs (NH),
1731vs (CO, free glycine arms) and 1641vs (CO, glycinato and
hydroxamato); ESI-MS m/z: 978 ([M–H]−).
[Ru(H2edta)(bha)]·2H2O (6)
Yield: 0.55 g, 68%. (Found: C, 36.4; H, 4.1; N, 7.3%. Calc. for
RuC17H24N3O12: C, 36.2; H, 4.3; N, 7.5%); mmax/cm−1 3195s (NH),
1731s (CO, free glycine arms) and 1634vs (CO, glycinato and
hydroxamato); leff = 1.76 lB.
[Ru(H2edta)(3-NH2-pha)]·2H2O (7)
Yield: 0.12 g, 53%. (Found: C, 35.2; H, 4.2; N, 10.0%. Calc.
for RuC17H25N4O12: C, 35.3; H, 4.4; N, 9.7%); mmax/cm−1 3264b
(NH), 1729s (CO, free glycine arms) and 1624vs (CO, glycinato
and hydroxamato); ESI-MS m/z: 544 ([M + H]+).
[Ru(H2edta)(4-NH2-pha)]·4H2O (8)
Yield: 0.54 g, 61%. (Found: C, 32.9; H, 4.5; N, 9.0%. Calc. for
RuC17H29N4O14: C, 33.2; H, 4.8; N, 9.1%); mmax/cm−1 3442vs,
3380vs, 3233s (NH), 1730s (CO, free glycine arms) and 1629vs
(CO, glycinato and hydroxamato).
[Ru(H2edta)(2-Cl-pha)]·H2O (9)
Yield: 0.084 g, 38%. (Found: C, 35.5; H, 3.7; N, 7.2%. Calc. for
RuC17H21N3ClO11: C, 35.2; H, 3.65; N, 7.25%); mmax/cm−1 3211s
(NH), 1730s (CO, free glycine arms) and 1635vs (CO, glycinato
and hydroxamato).
[Ru(H2edta)(3-Cl-pha)]·2H2O (10)
Yield: 0.26 g, 43%. (Found: C, 34.3; H, 3.4; N, 6.8%. Calc. for
RuC17H23N3ClO12: C, 34.15; H, 3.9; N, 7.0%); mmax/cm−1 3167s
(NH), 1732s (CO, free glycine arms) and 1650vs (CO, glycinato
and hydroxamato); ESI-MS m/z: 563 ([M + H]+).
[Ru(H2edta)(4-Cl-pha)]·2H2O (11)
Yield: 0.32 g, 55%. (Found: C, 34.4; H, 3.6; N, 6.8%. Calc. for
RuC17H23N3ClO12: C, 34.15; H, 3.9; N, 7.0%); mmax/cm−1 3297vs
(NH), 1731s (CO, free glycine arms), 1648vs (CO, glycinato) and
1610s (CO, hydroxamato).
[Ru(H2edta)(2-Me-pha)]·2H2O (12)
Yield: 0.045 g, 20%. (Found: C, 37.1; H, 4.3; N, 6.8%. Calc. for
RuC18H26N3O12: C, 37.4; H, 4.5; N, 7.3%); mmax/cm−1 3228vs (NH),
1730s (CO, free glycine arms) and 1630vs (CO, glycinato and
hydroxamato).
[Ru(H2edta)(3-Me-pha)]·2H2O (13)
Yield: 0.053 g, 24%. (Found: C, 37.2; H, 4.4; N, 7.0%. Calc. for
RuC18H26N3O12: C, 37.4; H, 4.5; N, 7.3%); mmax/cm−1 3221vs (NH),
1730 s (CO, free glycine arms) and 1632vs (CO, glycinato and
hydroxamato); ESI-MS m/z: 543 ([M + H]+).
[Ru(H2edta)(4-Me-pha)]·2H2O (14)
Yield: 0.096 g, 40%. (Found: C, 37.3; H, 4.2; N, 7.0%. Calc. for
RuC18H26N3O12: C, 37.4; H, 4.5; N, 7.3%); mmax/cm−1 3228vs (NH),
1730s (CO, free glycine arms) and 1630vs (CO, glycinato and
hydroxamato).
Syntheses of RuII-nitrosyl complexes
Reaction of K[Ru(Hedta)Cl]·2H2O with achaH, bhaH, 2-, 3- or 4-
NH2-phaH, 2-, 3- or 4-Cl-phaH and 2-, 3- or 4-Me-phaH and 2,6-
pyhaH2 under reﬂux, resulted in the facile formation of the brown
RuII-nitrosyl adduct of formula K[Ru(Hedta)(NO)Cl] regardless
of hydroxamic acid used. In contrast, 1,3- and 1,4-bhaH2, when
reactedwithK[Ru(Hedta)Cl] under reﬂux, gave the corresponding
red RuIII-dihydroxamates in high yield and the nitrosyl adduct
could only be isolated as a minor product upon puriﬁcation of
the ﬁltrates using a sephadex LH20 column. A typical synthesis is
described below. Reaction of K[Ru(Hedta)Cl]·2H2O with N-Me-
phaH did not produce a nitrosyl product, rather it resulted in the
formation of [Ru(H2edta)(N-Me-bha)]·H2O 2 only.
K[Ru(Hedta)(NO)Cl]·H2O (15)
An aqueous solution (20 cm3) of benzohydroxamic acid (bhaH)
(0.41 g, 3.0 mmol) was added to an aqueous solution (15 cm3)
of K[Ru(Hedta)Cl]·2H2O (0.5 g, 1.0 mmol), resulting in a red
solution. Upon heating, the reaction solution turned brown in
colour. It was reﬂuxed for ∼30min and then concentrated in vacuo
(10 cm3). After overnight refrigeration a white precipitate was
ﬁltered and dried. The brown ﬁltrate was taken to dryness on a
rotary evaporator. The resulting brown precipitate was stirred in a
1 : 1 diethyl ether–ethyl acetate suspension overnight. The brown
product was ﬁltered, puriﬁed on a sephadex column LH20 using
water as eluent to give 15 (0.29 g, 58%) as a brown solid (Found: C,
23.4; H, 2.9; N, 8.5; Cl, 6.9; K, 7.4%. Calc. for RuC10H15N3ClKO10:
C, 23.4; H, 2.95; N, 8.2; Cl, 6.9; K, 7.6%); dH (400 MHz; D2O;
Me4Si) 4.43 (d, 2H, CH2 glycine), 4.34 (s, 2H, CH2 glycine), 4.09
(2H, s, CH2 glycine), 3.84 (2H, s, CH2 glycine) 3.61 (4H, m,
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CH2 ethylenediamine); dC (400 MHz; D2O; Me4Si) 181.8, 178.5
(CO, glycinato), 177.7, 168.8 (CO, free glycine), 65.45, 65.4, 64.7,
64.3 (CH2 glycinato), 62.8, 60.4 (CH2 ethylenediamine); mmax/cm−1
3345 s (OH), 2986 s, 2947 s (CH, H2edta), 1894vs (NO), 1726s
(CO, free glycine arms) and 1649b (CO, glycinato); ESI-MS m/z:
456 ([M–H]−).
Potentiometric and spectrophotometric studies
The pH-metric titrations were carried out on a Molspin pH
meter and titration controller with Thermo Russell CMAW711
combined electrode and Hamilton syringe autoburette. All mea-
surements were carried out using solutions of 0.1 mol dm−3 ionic
strength (KNO3) at 25 ± 0.1 ◦C. Carbonate-free KOH solution
of known concentrations (ca. 0.2 mol dm−3), standardised with
potassium hydrogen phthalate,17 were used as titrant. In the
RuIII(edta) hydroxamic acid titrations readings were taken every
3 seconds to a precision of 0.001 pH units using the Molspin
titrator set on ‘slow reaction rate’. Aminimumnumber of readings
is used to calculate the standard deviation and this is compared
to the required precision. This process is repeated between 9 and
900 times until the standard deviation is less than the required
precision. This ensures that pH data are collected for a fully
equilibrated system. Each titration curve was carried out in
triplicate and 120 points per titration were used to calculate the
experimental equilibrium constants.
The electrode system was calibrated by the method of Irving
et al.18 (pKw = 13.831) so that the pH-meter readings could
be converted into hydrogen ion concentration. For the RuIII
systems sufﬁcient time was allowed for equilibration prior to pH
measurements.
The pKa values of the hydroxamic acids and of the aqueous
K[Ru(Hedta)Cl]·2H2O system were determined by titrating so-
lutions (∼2.0 × 10−3 mol dm−3) in HNO3 (5.0 × 10−3 mol dm−3)
with aKOH solution of known concentration (0.19807mol dm−3).
This method was also used to determine the exact concentration
of the ligand and metal stock solutions. Stability constants of
the RuIII-edta-hydroxamato complexes were determined by pH-
metric methods using ligand concentrations in the range 1 × 10−3
to 4 × 10−3 mol dm−3. The resulting data were analysed using
HYPERQUAD2000.19
UV-VIS spectroscopic investigation
A UV-VIS spectroscopic investigation was performed at 50 ◦C
on a Thermo Spectronic Helios a UV-Vis spectrophotometer
equipped with a thermostatted cell. The reduction in absorbance
at kmax corresponding to the hydroxamato ligand-to-RuIII metal
charge transfer (LMCT) band of the RuIII-hydroxamato species
[Ru(edta)(monoha)]2− (wheremonoha is acha, bha, 2-, 3- or 4-NH2-
pha, 3-Me-pha) was followed. Typical experimental conditions
were pH 4.50, ligand to metal ratio of 10 : 1, [Ru] = 2.00 mM
and I = 0.20 KCl thus ensuring good pseudo-ﬁrst-order plots of
ln(At − A∞) versus time where At and A∞ are the absorbances
at time t and inﬁnity, respectively. The metal complex solutions
were freshly prepared before each experiment. The temperature
(± 0.5 ◦C) of the cell housing was regulated by circulation of
thermostatted water.
Results and discussion
Synthesis and spectroscopic characterisation of hydroxamic acids
and their RuIII-hydroxamato complexes
Hydroxamic acids
The hydroxamic acids were synthesised according to literature
methods,20 by reaction of hydroxylamine with the corresponding
carboxylic methyl or ethyl esters, with the exception of N-
methylbenzohydroxamic acid, which was synthesised from a
carboxylic acid chloride.15 They were obtained in good yields
(∼50–80%) and high purity, and were characterised by elemental
analysis, IR and 1H NMR spectroscopy.
Selected IR stretches are given in Table 1. Occasionally, two
sharp stretches corresponding to the symmetric and asymmetric
mCO are observed but typically only one broad band appears due
to intramolecular hydrogen bonding.21 The mNH of the hydroxamic
acid is generally observed between 3150 and 3350 cm−1. The broad
mOH of the hydroxamic acid may be attributed to intermolecular
hydrogen bonding and is in the main observed in the range 2730 to
2930 cm−1. These values concur with previously reported literature
values.21
1H NMR spectra for the hydroxamic acids in d6 DMSO show
the hydroxamic acid NH and OH resonances at ca. 9 and 11 ppm,
respectively. The appearance of these resonances are very much
concentration-dependent due to intermolecular hydrogen bonding
at high concentrations.
Ru complexes
K[Ru(Hedta)Cl]·2H2O
Previous attempts to synthesise RuIII-hydroxamato complexes
using RuCl3·xH2O were hampered by the formation of ill-deﬁned
oligomeric products. Therefore with a view to synthesising and
characterising RuIII-hydroxamato derivatives, a well-characterised
RuIII complex K[Ru(Hedta)Cl]·2H2O was selected where the
ligand Hedta3− is pentadentate with one uncoordinated and
protonated glycine moiety. It was prepared by modiﬁcation of
a literature method16 and obtained in good yield (63%) and high
purity. Its IR spectrum exhibits two mCO stretches; the ﬁrst, a broad
band at 1632 cm−1, is attributed to the carbonyl groups of the Ru-
bound glycinato groups and the second, a very distinct sharp band
at 1726 cm−1, attributed to the carbonyl group of the protonated
free glycine arm of Hedta.22
Mononuclear RuIII-hydroxamato complexes
K[Ru(Hedta)Cl] rapidly forms the aqua species when dissolved
in water and exists predominantly in its most labile form
[RuIII(edta)(H2O)]− between pH 5–6.23 Reaction of an excess of
hydroxamic acid with [RuIII(edta)(H2O)]− in aqueous solution
afforded the corresponding RuIII-monohydroxamato complexes
of general formula [Ru(H2edta)(monoha)] (monoha = bha, 3- or
4-NH2-pha, 2-, 3- or 4-Cl-pha, 2-, 3- or 4-Me-pha, NMe-pha)
in varying yields but high purity, Scheme 1. All complexes were
characterised by IR spectroscopy, elemental analysis and in certain
instances by electrospray ionisation mass spectroscopy (ESI-MS)
and magnetic susceptibility measurements.
This journal is © The Royal Society of Chemistry 2008 Dalton Trans., 2008, 137–147 | 141
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Scheme 1
Although numerous attempts were made to isolate crystals
suitable for an X-ray crystallographic study, only crystals of
[Ru(H2edta)(2-OMe-pha)]·2H2O ever materialised, the crystal
structure of which was previously reported.14 Nevertheless, com-
parison of the IR spectra of our complexes with the IR spectrum
of [Ru(H2edta)(2-OMe-pha)]·2H2O, assisted in the successful
characterisation of the RuIII-hydroxamato complexes synthesised.
The coordination geometry of [Ru(H2edta)(2-OMe-pha)]·2H2O
is a slightly distorted octahedron as expected due to the presence
of different donor atoms. H2edta is present as a 2N, trans-2O-
(dicarboxylato) tetradentate ligand with two fully protonated
uncoordinated carboxylic acid moieties. The hydroxamato ligand,
2-MeO-pha, is coordinated to the RuIII centre in typical (O,O′)-
bidentate fashion.14
The IR spectra of the RuIII-hydroxamato complexes display
three distinctive mCO bands. Using [Ru(H2edta)(4-Cl-pha)]·2H2O
as a representative example, the band at 1610 cm−1 is attributed
to the hydroxamato carbonyl and is approximately 40 cm−1 less
than that observed in the spectrum of the free ligand, indicative
of hydroxamato coordination. The mCO at 1648 cm−1 and at
1731 cm−1 can be assigned to the carbonyl groups of the metal-
bound glycinato and glycine arms of edta, respectively. In most
cases the mCO of the hydroxamato ligand and bound glycinato
arms of edta are merged and appear as one broad band instead
of the expected two sharp, distinct bands. A hydroxamato mNH
is also observed at 3297 cm−1. In general the spectra of the
RuIII-hydroxamato complexes display mNH from ca. 3200 to 3350
cm−1 while [Ru(H2edta)(N-Me-bha)] displays a strong mCH of the
hydroxamato N–CH3 group at 3494 cm−1. The IR spectra of
the RuIII-hydroxamato complexes exhibit the same overall pattern
as was evidenced for [Ru(H2edta)(2-OMe-pha)]·2H2O, indicating
that they all have similar structures, particularly with respect to
denticity and protonation state of the edta ligand, hydroxamato
binding mode and geometry of the complexes. They are also in
agreement with previously reported data.14 Selected mononuclear
RuIII-hydroxamato complexes were further identiﬁed by ESI-MS
in the positive mode. Mass peaks at 543, 544, 563 and 543 amu are
observed for [Ru(H2edta)(N-Me-bha)] (542), [Ru(H2edta)(3-NH2-
pha)] (543), [Ru(H2edta)(3-Cl-pha)] (562) and [Ru(H2edta)(3-Me-
pha)] (542), respectively, and all of which display the correct iso-
topic abundances. The room temperature leff of the mononuclear
[Ru(H2edta)(bha)]·2H2O and [Ru(H2edta)(N-Me-bha)]·H2O are
1.79 lB and 1.89 lB, respectively, and fall within the range of 1.7
to 2.3 lB, typical of a low-spin paramagnetic RuIII complex with
an electron conﬁguration t2g5eg0 at this temperature.
The RuIII-hydroxamato complexes of bhaH and the monosub-
stituted aromatic derivatives 3- and 4-NH2-phaH, 2-, 3- and 4-Cl-
phaH, 2-, 3- and 4-Me-phaH, are schematically represented by the
general formula [Ru(H2edta)(monoha)], shown in Scheme 1.
Of the red RuIII-hydroxamato complexes synthesised, all but
one yielded products of general formula [Ru(H2edta)(monoha)]
(where monoha = bha, 3- or 4-NH2-pha, 2-, 3- or 4-Cl-pha, 2-,
3- or 4-Me-pha) and the % yields follow the substitution order
2- < 3- < 4-. Reaction of K[Ru(Hedta)Cl]·2H2O with 2-NH2-
phaH failed to yield the desired product, [Ru(H2edta)(2-NH2-
pha)], rather a blue solution resulted, which rapidly changed
to brown, from which a brown solid was subsequently isolated
and characterised as the RuII-nitrosyl, K[Ru(Hedta)(NO)Cl].
Blue RuIII-edta-catecholamine complexes have previously been
reported.24 The N-methyl-substituted derivative, [Ru(H2edta)(N-
Me-bha)], obtained in high yield and high purity, is the ﬁrst of its
kind with RuIII to be reported.
Dinuclear RuIII-hydroxamato complexes
To date, there have been no reports in the literature on RuIII-
dihydroxamato complexes. A NiII(2,6-pyha) complex has been
reported where the dihydroxamato ligand chelates the NiII ion
142 | Dalton Trans., 2008, 137–147 This journal is © The Royal Society of Chemistry 2008
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via the {N,Npy,N} donor set to give a discrete mononuclear
[PPh4]2[Ni(2,6-pyha)2]·7H2O complex.25 Another report describes
the use of 1,3-benzodihydroxamic acid (L) in the construction of
an Fe4L6 pyramid and consequently a three-dimensional porous
metal–organic framework.26 Herein, we report reaction of the
dihydroxamic acids, 1,3-bhaH2, 1,4-bhaH2 and 2,6-pyhaH2 with
2 equivalents of K[Ru(Hedta)Cl], which affords novel dinu-
clear RuIII-dihydroxamato complexes [{Ru(H2edta)}2(l-1,3-bha)],
[{Ru(H2edta)}2(l-1,4-bha)] and [{Ru(H2edta)}2(l-2,6-pyha)], re-
spectively (Fig. 2), where the dihydroxamic acids coordinate
in a bridging fashion via two independent O,O′ donor head
groups. Elemental analyses and ESI-MS for the dinuclear RuIII-
dihydroxamato complexes, together with the potentiometric study
(discussed later) and a comparison of their IR spectra versus
those of the free dihydroxamic acids, unambiguously conﬁrm the
formation of the bridging dihydroxamato complexes. In the IR
spectrum of [{Ru(H2edta)}2(l-1,4-bha)]·2H2O, for example, a mCO
at 1668 cm−1 and at 1724 cm−1 can be assigned to the stretching
frequencies of the carbonyl groups of the glycinato and free glycine
arms of edta, respectively. The mCO at 1609 cm−1 is that of the
hydroxamato carbonyl groups and is approximately 40 cm−1 less
than that observed in the spectrum of the free ligand, indicative of
hydroxamato (O,O′) coordination.
Fig. 2 Structures of [{Ru(H2edta)}2(l-1,4-bha)] 3, [{Ru(H2edta)}2-
(l-1,3-bha)] 4 and [{Ru(H2edta)}2(l-2,6-pyha)] 5.
ESI-MS in the negativemodewas used to unequivocally identify
the dinuclear RuIII-dihydroxamato complexes; mass peaks at 977,
977 and 978 amu were observed for [{Ru(H2edta)}2(l-1,3-bha)]
(978), [{Ru(H2edta)}2(l-1,4-bha)] (978) and [{Ru(H2edta)}2(l-
2,6-pyha)] (979), and all of which display the characteristic
Ru isotopic abundances. [{Ru(H2edta)}2(l-1,4-bha)]·2H2O was
also found to have a magnetic moment of 2.16 lB at room
temperature, typical of a low-spin paramagnetic RuIII complex
and indicative of no magnetic exchange between the RuIII centres
at this temperature. In the IR spectra of both [{Ru(H2edta)}2(l-
1,3-bha)]·4H2O and [{Ru(H2edta)}2(l-2,6-pyha)]·4H2O, the mCO of
the hydroxamato and edta glycinato arms are merged and appear
as one broad band.
Formation constants and species-distribution curves
Speciation and spectroscopic studies were carried out on ligands
L where L is 3- and 4-NH2-phaH, 4-NMe2-phaH, 2-, 3- and
4-Cl-phaH, 3-Me-phaH and their complexes with the binary
RuIII-edta system and the results support the presence of the
ternary RuIII-edta-hydroxamato complexes of general formula
[Ru(edta)(monoha)]2−, similar to those found in the solid state (3–
11 and 13). The 2-Me-pha and 4-Me-pha systems were previously
reported.14
The ternary RuIII-edta-monohydroxamic acid systems
The pKa values for the ligands synthesised, the details of which
are given in Table 2, are as one would expect with 4-NMe2-phaH
having the highest pKa value (9.47) and 2-Cl-phaH having the
lowest (8.27). The stability constants of the aromatic hydroxamato
complexes of general formula [Ru(edta)(monoha)]2− orML, (where
monoha or L = bha or its monosubstituted derivatives 3-NH2-
pha, 4-NH2-pha, 2-Cl-pha, 3-Cl-pha, 4-Cl-pha, 3-Me-pha and
4-NMe2-pha), were obtained pH-metrically and lie in the range
6.15(4)–7.05(1), Table 2.
With the exception of the 4-NMe2-pha derivative,
[Ru(edta)(NMe2-pha)]2− (log b = 7.32(3)), all the complexes
studied (in which the ratio of RuIII : monohydroxamic acid ligand
was 1 : 1), having log b values ranging from 6.15(4) to 7.05(1),
are less stable than the previously reported benzohydroxamato
Ru(edta) complex, [Ru(edta)(bha)]2− (log b = 7.28(1)),14 despite
the variance in basicity of ligands studied relative to the
benzohydroxamato ligand. Interestingly also is the fact that,
although the order of basicity of the amino derivatives is 4-NMe2-
phaH >2-NH2-phaH >3-NH2-phaH >4-NH2-phaH, the order
of complex stability is [Ru(edta)(NMe2-pha)]2− > [Ru(edta)(4-
NH2-pha)]2− > [Ru(edta)(3-NH2-pha)]2−. Species distribution and
formation constants for the 2-NH2-pha system were not obtained
as 2-NH2-phaH reacted quickly and irreversibly with the Ru(edta)
system to form the nitrosyl adduct. Therefore competing nitrosyl
formation hampered the speciation studies for ternary systems
involving 2-NH2-phaH. It is also noteworthy that para-substituted
Ru(phenylhydroxamato) complexes were more stable than the
corresponding meta-substituted phenylhydroxamato complexes,
which were in turn more stable than the ortho-substituted
derivatives despite the different electronic properties associated
with the different substituents where the order of stability of
the ML species was: 4-NMe2-pha > bha > 4-NH2-pha > 4-Cl-
phaH > 3-Me-phaH > 3-NH2-pha > 3-Cl-phaH > 2-Cl-pha,
Table 2.
The titration curve for the ternary Ru-3-NH2-phaH system, as
a representative example, and typical of the Ru-monohydroxamic
This journal is © The Royal Society of Chemistry 2008 Dalton Trans., 2008, 137–147 | 143
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acid systems studied, is shown in Fig. S1 (see ESI†) and is
compared to those for the free ligand 3-NH2-phaH and the
binary [Ru(Hedta)Cl]−. In the ternary system there are three
dissociable protons below pH 10; the ﬁrst two correspond to
deprotonation of the Hedta ligand and the hydroxamic acid
leading to [Ru(edta)(3-NH2-pha)]2− and the third ionisation, in
weakly alkaline solution, is due to deprotonation of the NH group
of the coordinated hydroxamato giving the dianionic hydroximato
complex [Ru(edta)(3-NH2-phaH−1)]3−.
The concentration-distribution curves for the ternary Ru-3-
NH2-phaH system, again described here as a representative ex-
ample, are shown in Fig. 3 and Fig. 4. The yellow-coloured binary
Ru(edta) complex reacts with 3-NH2-phaH from ca. pH 3.3 to give
the red [Ru(edta)(3-NH2-pha)]2− complex, which is the dominant
species between ca. pH 5.3–7.2. [Ru(edta)(3-NH2-pha)]2− has a
maximum concentration at pH 6.4 whereupon deprotonation
of the hydroxamato NH group commences, resulting in the
formation of the purple doubly deprotonated hydroximato com-
plex [Ru(edta)(3-NH2-phaH−1)]3−, the major species in solution
between ca. pH 7.0–10.0. Above ca. pH 7.5, the hydroxo complex
[Ru(edta)(3-NH2-phaH−1)(OH)]4− is observed.
Fig. 3 Species distribution for RuIII-3-NH2-phaH, [RuIII] = 2 mM,
RuIII–3-NH2-phaH = 1 : 1.
Fig. 4 Species distribution for RuIII-1,3-bhaH2, [RuIII] = 2 mM,
RuIII–1,3-bhaH2 = 2 : 1.
Although several examples involving hydroximato coordination
have been cited in the literature, these mainly involve oligonuclear
metallacrowns.1 In addition to our previous report detailing the
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only examples ofRuIII hydroxamato and hydroximato complexes,14
there are only a handful of reports on deprotonation of hy-
droxamato to hydroximato ligands in mononuclear complexes.
Hydroximato complexes of Cu27 andV28 at high pHwere identiﬁed
by EPR spectroscopy and those of Mo by 17O and 1H NMR
spectroscopy.29 Benzo- and anthranilo-hydroximato manganate
(IV and III respectively) complexes have also been reported.30
A more recent report by Hambley and co-workers details an
elegant study whereby, upon manipulation of pH, they were
successful in isolating either the hydroxamato or hydroximato
CoIII-tpa (tpa is tris(2-methylpyridyl)amine) complexes in the
solid state including the mononuclear hydroximato complexes
[Co(achaH−1)tpa]ClO4·0.5H2O, [Co(pphaH−1)tpa](ClO4)0.5·4H2O
and [Co(bhaH−1)tpa]Cl·6H2O where achaH−1, pphaH−1 and
bhaH−1 are acetohydroximato, propionhydroximato and benzo-
hydroximato, respectively, and the crystal structures of which
they reported. They also report a crystal structure in which
the asymmetric unit consists of two independent molecules,
with one each of the hydroxamato, [Co(acha)(tpa)] and hydrox-
imato, [Co(achaH−1)(tpa)] forms of the acetohydroxamic acid
ligand.9
The ternary RuIII-edta-dihydroxamato systems
The pKa values for the dihydroxamic acids, 1,3-bhaH2 (8.04 and
9.20) and 2,6-pyhaH2 (2.34, 7.81 and 9.09) were calculated, the
former values of which have not previously been reported, Table 2.
The titration curve for the ternary Ru-1,3-bhaH2 system, as
a representative example, and typical of the dihydroxamic acids
studied, is shown in Fig. S2 (see ESI†) and is compared to that
of the free ligand 1,3-bhaH2 and the binary [Ru(Hedta)Cl]−. In
these studies, there was a 4 : 1 excess of RuIII to dihydroxamic
acid used to ensure that all ligand present reacted with the RuIII.
Two deprotonation processes were observed for the ligand; upon
titration with KOH, two protons are released, one from each of
the hydroxamatoOHgroups, Table 2. Four dissociable protons are
observed in the ternaryRu-edta-1,3-bhaH2 systembelowpH7, the
ﬁrst two ofwhich correspond to deprotonation of theHedta ligand
followed by deprotonation of the two hydroxamato moieties of
1,3-bhaH2 leading to the formation of [{Ru(edta)}2(l-1,3-bha)]4−,
the major species present in solution between pH 5.2–8.2, Fig. 4.
Underweakly alkaline conditions, deprotonation of one of the two
NH’s of the coordinated 1,3-bha is observed giving the novel triply
deprotonated trianionic hydroximato complex [{Ru(edta)}2(l-1,3-
bhaH−1)]5−.
The pKa values for the RuIII dihydroxamato complexes,
[{Ru(edta)}2(l-1,3-bha)]4− and [{Ru(edta)}2(l-2,6-pyha)]4−, cor-
responding to deprotonation of hydroxamato NH protons were
found to be 8.21 and 7.76, respectively, Table 2. These values are
higher compared to the Ru monohydroxamato complexes due to
the increased overall negative charge of their conjugate acids i.e.
4- in the case of the dihydroxamato complexes, [{Ru(edta)}2(l-
diha)]4− compared to 2- for the monohydroxamato complexes,
[Ru(edta)(monoha)]2−. With the exception of [{Ru(edta)}2(l-1,4-
bha)]4− (which could not be investigated potentiometrically due to
poor aqueous solubility although the complex [{Ru(H2edta)}2(l-
1,4-bha)]·4H2O was isolated in the solid state) the stability
constants of the dihydroxamato complexes of general formula
[{Ru(edta)}2(l-diha)]4− or M2L were obtained pH-metrically. The
[{Ru(edta)}2(l-1,3-bha)]4− complex has a slightly higher log b
value relative to the [{Ru(edta)}2(l-2,6-pyha)]4− complex, Table 2.
The concentration distribution curves for the Ru-1,3-bhaH2
system, again as a representative example, are shown in Fig. 4 and
are the ﬁrst of their kind tobe reported in the literature. The yellow-
coloured binary Ru(edta) complex reacts with 1,3-bhaH2 from
ca. pH 4 to give the reddish–brown [{Ru(edta)}2(l-1,3-bha)]4−
complex, which is the dominant species between ca. pH 5.2–8.2.
This species has a maximum concentration at ca. pH 7 whereupon
deprotonation of only one of the two hydroxamato NH groups
commences. This results in the formation of [{Ru(edta)}2(l-
1,3-bhaH−1)]5−, with one hydroxamic acid function coordinated
to RuIII via (O,O′) hydroxamato where the NH remains intact
while the other is coordinated to the second RuIII in the doubly
deprotonated (O,O′) hydroximato formwith deprotonatedN. This
is the major species in solution above ca. pH 8.2.
The formation of [{Ru(edta)}2(l-1,3-bhaH−1)]5−, where one of
the two hydroxamato NH groups is deprotonated, was conﬁrmed
by a UV-VIS spectrophotometric study. As can be seen from
Fig. 5, upon increasing pH from 7.5 to 9.3, the colour of the
solution changes from red to purple and the LMCT band corre-
sponding to the hydroxamato O–RuIII transition shifts to longer
wavelength due to the formation of the new hydroximato com-
plex [{Ru(edta)}2(l-1,3-bhaH−1)]5− and consistent with previously
reported metal hydroxamato to hydroximato conversion. This
shift was not observed for [Ru(edta)(N-Me-acha)]2−, as previously
reported, where such a deprotonation could not occur.14 Beyond
pH 8.5, there is no further shift in kmax, indicative of the presence of
only one species i.e. [{Ru(edta)}2(l-1,3-bhaH−1)]5−. The presence
of this species was further supported by our speciation studies,
Fig. 5.
Fig. 5 UV-VIS spectra of K[RuIII(Hedta)Cl]·2H2O+ 1,3-bhaH2, [RuIII]=
2 lM, [1,3-bhaH2] = 1 mM, initial volume 5 mL, titrated with 0.5 M
KOH; spectra 1: pH 7.5; spectra 2: 7.9; spectra 3: pH 8.5; spectra 4: 9.3.
[{Ru(edta)}2(l-1,3-bha)]4−, kmax = 534 nm; [{Ru(edta)}2(l-1,3-bhaH−1)]5−,
kmax = 554 nm.
RuII-nitrosyl complexes
Reaction of K[Ru(Hedta)Cl]·2H2O with achaH, bhaH, 2-, 3-
or 4-NH2-phaH, 2-, 3- or 4-Cl-phaH and 2-, 3- or 4-Me-phaH
and 2,6-pyhaH2 on heating, resulted in the facile formation of
the brown RuII-nitrosyl adduct of formula K[Ru(Hedta)(NO)Cl]
regardless of the hydroxamic acid used. Elemental analysis, IR,
1H and 13C NMR spectrum are consistent with the formulation
K[RuII(Hedta)(NO)Cl]·H2O, and concur with previously reported
This journal is © The Royal Society of Chemistry 2008 Dalton Trans., 2008, 137–147 | 145
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examples of RuII-edta-NO complexes in the literature.22 The IR
spectra of K[Ru(Hedta)(NO)Cl]·H2O contains a distinctive mNO at
1894 cm−1. ESI-MS in the negative mode was used to unequivo-
cally identify the RuII-NO complex, [RuII(Hedta)(NO)Cl]−; a mass
peak at 456 amu with the characteristic Ru isotopic abundance
was observed. Interestingly, we found that the N-substituted
hydroxamic acid, N-Me-bhaH, lacking the NH hydroxamato
proton, regardless of the reaction conditions, did not release NO.
In contrast, 1,3- and 1,4-bhaH2, when reacted with
K[Ru(Hedta)Cl] under reﬂux, predominately gave the corre-
sponding dinuclear RuIII-dihydroxamato complexes and while the
nitrosyl adduct could be isolated, it was obtained as the minor
product.
Nitrosyl abstraction from hydroxamic acids
As previously reported by us, K[Ru(Hedta)Cl] abstracts NO from
hydroxamic acids on heating to form the stable RuII-nitrosyl
complex K2[RuII(edta)(NO)Cl] and the corresponding carboxylic
acid. We proposed that this reaction involves initial formation of a
[RuIII(edta)(hydroxamato)]2− complex that undergoes nucleophilic
attack by hydroxide on the hydroxamato carbonyl carbon, to give
a tetrahedral intermediate from which hydroxylamine (a known
source of NO) is eliminated with subsequent formation of the
RuII-nitrosyl complex [RuII(edta)(NO)Cl]2−. We found that the
optimum pH for nitrosyl formation was at ca. pH 4.5. Above
this pH, the RuIII hydroximato complex (via deprotonation of
the hydroxamato N) starts to form and, as previously reported
by us, this species cannot release NO under these experimental
conditions.14 However, it is noteworthy that, under physiological
conditions, hydroxamic acids have been shown to release NO via
a NO-mediated Fe-haem containing guanylate cyclase pathway.3
UV-VIS spectroscopic investigation
We decided to carry out a UV-VIS spectroscopic investigation
to determine the rate of NO release from the aliphatic aceto-
hydroxamic acid, the aromatic benzohydroxamic acid and from
substituted benzohydroxamic acids where the substituents were
either electron-withdrawing (–Cl) or electron-releasing (–NH2
and/or –Me). Of the hydroxamic acids reported in this paper,
all but the chloro derivatives could be investigated for NO release.
Whilst they were sufﬁciently soluble for speciation studies, this was
not the case for our kinetic investigation where the required ratio
of ligand to RuIII was 10 : 1. In any case, the rate of NO release
from a total of 6 hydroxamic acids was investigated.
We reacted K[Ru(Hedta)Cl] with achaH, bhaH, 3-NH2-phaH
and 3-Me-phaH in ten-fold excess at pH 4.50 and at 50 ◦C
in acetic acid–sodium acetate buffer and followed the reaction
by UV-VIS spectroscopy. The formation of the ternary complex
[Ru(edta)(monoha)]2− is marked by a colour change from yellow to
red and the appearance of a hydroxamato ligand to RuIII charge-
transfer band. As the reaction proceeds at this pH, this LMCT
band diminishes with time with a marked colour change from red
to brown indicative of conversion of the RuIII-hydroxamato com-
plex to the RuII-nitrosyl adduct, [RuII(edta)(NO)Cl]−, Scheme 2,
and consistent with our solid-state study. BecauseNO release from
the RuIII(edta)(3-NH2-pha) complex proved fastest, we decided to
further investigate the rate of NO release from the RuIII(edta)(2-
Table 3 kobs and kmax for [Ru(edta)(monoha)]2− where monoha = 2-, 3-,
4-NH2-pha, acha, bha and 3-Mepha
kmax/nm kobs/min−1
[Ru(edta)(2-NH2-pha)]2− 525 0.1381
[Ru(edta)(4-NH2-pha)]2− 516 7.7 × 10−3
[Ru(edta)(3-NH2-pha)]2− 485 7.2 × 10−3
[Ru(edta)(acha)]2− 455 2.3 × 10−3
[Ru(edta)(bha)]2− 481 1.6 × 10−3
[Ru(edta)(3-Me-pha)]2− 483 1.3 × 10−3
NH2-pha) and RuIII(edta)(4-NH2-pha) complexes with a view
to examining the effect of substituent position on the rate. A
summary of the results is given in Table 3.
TheUV-VIS spectra corresponding to theRu(edta)(3-NH2-pha)
system and described here as a representative example, Fig. 6,
exhibits a decrease in the LMCT band at 485 nm with time
and is indicative of conversion of [RuIII(edta)(3-NH2-pha)]2− to
[RuII(edta)(NO)Cl]−. Spectra were recorded at 15 min intervals
until such time as there was no further spectral change i.e. at time
t = 435 min in this case. A plot of ln(Abst−Abs∞) versus time gives
a straight line with a kobs = 7.2 × 10−3 min−1, where kobs represents
a combination of keq and k shown in Scheme 2. Of the hydroxamic
acids studied, the decrease in the LMCT band of [Ru(edta)(2-
NH2-pha)]2− was fastest with a kobs = 0.1381 min−1, most probably
due to the presence of the amino group at the 2-position relative to
the hydroxamato moiety, which can partake in hydrogen bonding
thereby stabilising the proposed tetrahedral intermediate in the
mechanism described earlier.
Fig. 6 UV-VIS spectra of the Ru(edta)-3-NH2-phaH system where
[RuIII] = 2 mM and [RuIII]–[3-NH2-phaH] = 1 : 10. Spectra recorded
at 15 min intervals, pH 4.50, 50 ◦C.
Scheme 2
Under the stated conditions, NO release from the RuIII-
acetohydroxamato complex is faster than that of the benzo-
hydroxamato derivative, not surprising given the fact that the
phenyl ring of the benzohydroxamato is electronwithdrawing. The
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[Ru(edta)(3-NH2pha)]2− complex releases NO over 5 times faster
than the 3-Me-substituted derivative [Ru(edta)(3-Mepha)]2−, sug-
gesting that mesomeric in addition to inductive effects have a role
to play.
Conclusions
In this paper we report the ﬁrst examples of dinuclear RuIII com-
plexes with bridging dihydroxamato and dihydroximato ligands of
general formula [{Ru(H2edta)}2(l-diha)] and [{Ru(H2edta)}2(l-
dihaH−1)]−1, respectively. A series of mononuclear RuIII hy-
droxamato and hydroximato complexes of general formula
[Ru(H2edta)(monoha)] and [Ru(H2edta)(monohaH−1)]−1, respec-
tively, as well as the ﬁrst example of a RuIII-N-aryl aromatic
hydroxamato derivative are reported. We also detail a UV-VIS
spectroscopic investigation where we monitored the decrease
in LMCT absorbance of a series of RuIII-monohydroxamato
complexeswith time, gaining a better insight into theNO-releasing
properties of aliphatic and aromatic hydroxamic acids.
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